Spark Investment Management LLC Aptinyx Inc. Transaction History

Spark Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$1.99 - $4.4 $66,298 - $146,590	-33,316 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$1.81 - $5.03 $21,024 - $58,428	11,616 Added 53.53%	33,316 $71,000
Q4 2019 Feb 11, 2020	BUY	$2.84 - $4.25 $61,628 - $92,225	21,700 New	21,700 $74,000
Q3 2019 Nov 12, 2019	SELL	$3.0 - $4.08 $146,700 - $199,512	-48,900 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$2.95 - $4.38 $33,925 - $50,370	-11,500 Reduced 19.04%	48,900 $163,000
Q1 2019 May 07, 2019	BUY	$3.99 - $19.33 $240,996 - $1.17 Million	60,400 New	60,400 $244,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.